Literature DB >> 2420467

Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.

J D Young, H Hengartner, E R Podack, Z A Cohn.   

Abstract

A cytolytic pore-forming protein (PFP, perforin) was purified from isolated granules of cloned NK-like cytolytic cells, which showed an apparent Mr of 70-75 kd (reduced) and 62-66 kd (nonreduced). Cytolysis produced by this protein occurred only in the presence of Ca2+ and was accompanied by the formation of membrane lesions of 160 A diameter. The purified protein depolarized cells and made lipid vesicles leaky to monovalent and divalent ions. This protein formed large, voltage insensitive and nonselective ion channels in planar bilayers that remained preferentially in the open state. The channels were heterogeneous in size distribution averaging 400 pS/U in 0.1 M NaCl. The membrane lesions formed by PFP were morphologically and functionally similar to those formed by intact NK-like cells and their granules. This PFP could be released from granules during cell killing, followed by its polymerization on target membranes to form large transmembrane pores.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420467     DOI: 10.1016/0092-8674(86)90007-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  81 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

Review 3.  Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Authors:  Richard Wu; Marie-Andrée Forget; Jessica Chacon; Chantale Bernatchez; Cara Haymaker; Jie Qing Chen; Patrick Hwu; Laszlo G Radvanyi
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

4.  The perforin mediated apoptotic pathway in lung injury and fibrosis.

Authors:  H Miyazaki; K Kuwano; K Yoshida; T Maeyama; M Yoshimi; M Fujita; N Hagimoto; R Yoshida; Y Nakanishi
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

5.  Cytolytic and ion channel-forming properties of the N terminus of lymphocyte perforin.

Authors:  D M Ojcius; P M Persechini; L M Zheng; P C Notaroberto; S C Adeodato; J D Young
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Authors:  J Jones; S Frith; S Piddlesden; B P Morgan; D A Compston; A K Campbell; M B Hallett
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

7.  Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.

Authors:  J Jones; B P Morgan
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

8.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Ischemic neurons recruit natural killer cells that accelerate brain infarction.

Authors:  Yan Gan; Qiang Liu; Wei Wu; Jun-Xiang Yin; Xue-Feng Bai; Rulong Shen; Yongjun Wang; Jieli Chen; Antonio La Cava; Jennifer Poursine-Laurent; Wayne Yokoyama; Fu-Dong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

10.  Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.

Authors:  C Fady; A Gardner; J F Gera; A Lichtenstein
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.